Articles related to INTRAOCULAR LENS (IOL)

Inconsistent cataract biometry measurements most commonly reflect ocular surface instability, subtle corneal pathology, or suboptimal measurement conditions rather than random error, and a systematic diagnostic approach before repeating scans can meaningfully improve refractive predictability.

Alcon’s Clareon TruPlus adds an enhanced monofocal option aimed at improving intermediate vision while preserving distance quality, with real‑world outcomes yet to be defined.

TECNIS PureSee IOL is the first and only US FDA‑approved extended depth of focus (EDOF) IOL with no warning on loss of contrast sensitivity

Blake Williamson, MD, MPH, MS, demonstrates femtosecond laser assisted cataract surgery (FLACS) with a toric lens and iStent inject.

For a comprehensive approach to refractive IOL surgery, understanding the nuances of preoperative assessment and ocular surface optimization is essential. Dive deeper into effective protocols to ensure optimal patient outcomes.

After cataract surgery, a fragment of the lens is thought to stay in the eye in 0.3% to 1.1% of cases. Following cataract surgery, the retained cortex and nucleus respond differently: While the nucleus triggers a potent, destructive inflammatory response, the cortex only induces low-grade inflammation. Increased postoperative drops are administered more frequently, and if necessary, IOP-lowering medications are added.